Australian radio therapeutics company Radiopharm Theranostics (ASX:RAD) has announced it expects to obtain a secondary listing on the Nasdaq Capital Market by the end of 2024. …
Radiopharm Theranostics targets Nasdaq listing by the end of 2024
July 29, 2024 Latest NewsAustralian Biotech
Latest Video
New Stories
-
Amplia announces capital raise to support the completion of Phase 2a ACCENT tr
October 30, 2024 - - Australian Biotech -
Priceline Pharmacy launches a refreshed brand strategy
October 30, 2024 - - Latest News -
Vaccine procurement and rollout was slow, but reduced the number of deaths
October 30, 2024 - - Latest News -
Boehringer Ingelheim leader promoted to global role
October 30, 2024 - - Latest News -
At least this means the industry will never again take lectures on these issues
October 29, 2024 - - Latest News -
Decisions taken during the caretaker period are governed by a formal convention
October 29, 2024 - - Latest News -
Community pharmacy leads nationwide transformation of women’s health services
October 29, 2024 - - Latest News